Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pBabe-lincRNA-RoR Citations (3)

Originally described in: Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells.
Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, Rinn JL Nat Genet. 2010 Dec;42(12):1113-7. Epub 2010 Nov 7.
PubMed Journal

Articles Citing pBabe-lincRNA-RoR

Articles
lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q. Mol Cancer Res. 2015 Feb;13(2):330-8. doi: 10.1158/1541-7786.MCR-14-0251. Epub 2014 Sep 24. PubMed
Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells. Duru N, Gernapudi R, Lo PK, Yao Y, Wolfson B, Zhang Y, Zhou Q. Oncotarget. 2016 Jul 26;7(30):47511-47525. doi: 10.18632/oncotarget.10203. PubMed
Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis. Li C, Zhao Z, Zhou Z, Liu R. Cancer Chemother Pharmacol. 2016 Dec;78(6):1199-1207. Epub 2016 Oct 26. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.